SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-043308
Filing Date
2024-04-10
Accepted
2024-04-10 15:35:15
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A evok-defa14_4.10.24.htm DEFA14A 25012
2 GRAPHIC img150748567_0.jpg GRAPHIC 237923
3 GRAPHIC img150748567_1.jpg GRAPHIC 139777
  Complete submission text file 0000950170-24-043308.txt   546165
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36075 | Film No.: 24835592
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)